Predicting second breast cancer among women with primary breast cancer using machine learning algorithms, a population‐based observational study

Author:

Syleouni Maria‐Eleni12,Karavasiloglou Nena13ORCID,Manduchi Laura4,Wanner Miriam2,Korol Dimitri2,Ortelli Laura5,Bordoni Andrea5,Rohrmann Sabine12ORCID

Affiliation:

1. Division of Chronic Disease Epidemiology, Epidemiology Biostatistics and Prevention Institute University of Zurich Zurich Switzerland

2. Cancer Registry Zurich, Zug, Schaffhausen and Schwyz University Hospital Zurich Zurich Switzerland

3. European Food Safety Authority Parma Italy

4. Medical Data Science, ETH Zurich Zurich Switzerland

5. Ticino Cancer Registry, Public Health Division of Canton Ticino Locarno Switzerland

Abstract

AbstractBreast cancer survivors often experience recurrence or a second primary cancer. We developed an automated approach to predict the occurrence of any second breast cancer (SBC) using patient‐level data and explored the generalizability of the models with an external validation data source. Breast cancer patients from the cancer registry of Zurich, Zug, Schaffhausen, Schwyz (N = 3213; training dataset) and the cancer registry of Ticino (N = 1073; external validation dataset), diagnosed between 2010 and 2018, were used for model training and validation, respectively. Machine learning (ML) methods, namely a feed‐forward neural network (ANN), logistic regression, and extreme gradient boosting (XGB) were employed for classification. The best‐performing model was selected based on the receiver operating characteristic (ROC) curve. Key characteristics contributing to a high SBC risk were identified. SBC was diagnosed in 6% of all cases. The most important features for SBC prediction were age at incidence, year of birth, stage, and extent of the pathological primary tumor. The ANN model had the highest area under the ROC curve with 0.78 (95% confidence interval [CI] 0.750.82) in the training data and 0.70 (95% CI 0.61‐0.79) in the external validation data. Investigating the generalizability of different ML algorithms, we found that the ANN generalized better than the other models on the external validation data. This research is a first step towards the development of an automated tool that could assist clinicians in the identification of women at high risk of developing an SBC and potentially preventing it.

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3